Effectiveness of Respiratory Protection During Simulated Resuscitation: a Prospective Cohort Study

November 6, 2020 updated by: Andrew Barros, University of Virginia

The study hypothesizes that EHMRs with P100 filters will provide superior respiratory protection during simulated CPR compared to disposable N95 FFRs as measured by qualitative fit testing.

To this end, the study is a prospective observational cohort to evaluate the effectiveness of disposable FFRs and EHMR during simulated CPR. The primary endpoint will be subject report of detection of the testing agent during a 2 minute session of simulated chest compressions on a mannequin while wearing the respiratory protection that subjects routinely wear during the course of employment.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Charlottesville, Virginia, United States, 22908
        • UVAHealth

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Current use of respirator within last 7 days
  • Completed fit test with respirator within last 2 years

Exclusion Criteria:

  • Previous adverse reaction to fit testing or testing agent
  • Development of any health problem that precludes use of a respirator since last occupational health evaluation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: N95 Filtering Facepiece Respirator
Subjects will wear the model of filtering facepiece respirator that they are currently approved to wear
Qualitative fit testing with denatonium benzoate
ACTIVE_COMPARATOR: Elastomeric Half-Mask Respirator with P100 filters
Subjects will wear the model of elastomeric half mask respirator that they are currently approved to wear.
Qualitative fit testing with denatonium benzoate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject Detection of Testing Agent
Time Frame: 2 minutes
Subject reported detection of testing agent
2 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to detection of testing agent
Time Frame: 2 minutes
Time to subject reported detection of testing agent
2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrew Barros, MD, University of Virginia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 26, 2020

Primary Completion (ACTUAL)

November 4, 2020

Study Completion (ACTUAL)

November 4, 2020

Study Registration Dates

First Submitted

October 12, 2020

First Submitted That Met QC Criteria

October 15, 2020

First Posted (ACTUAL)

October 19, 2020

Study Record Updates

Last Update Posted (ACTUAL)

November 9, 2020

Last Update Submitted That Met QC Criteria

November 6, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • HSR200209

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Occupational Exposure

Clinical Trials on Qualitative Fit Testing

Subscribe